New Consensus On Non Cirrhotic Portal Fibrosis
New Consensus On Non Cirrhotic Portal Fibrosis
New Consensus On Non Cirrhotic Portal Fibrosis
GUIDE: DR.ATUL SHENDE CANDIDATE:DR.SARATH MENON.R DIVISION OF GASTROENTEROLOGY MGM MEDICAL COLLEGE,INDORE
INTRODUCTION
Increase in portal pressure due to pre-sinusoidal (intrahepatic) or pre hepatic lesions Absence of cirrhosis
NCPF - DEFINITION
Disease of uncertain etiology Portal fibrosis & invlv. small and med.portal veins Portal hypertension,splenomegaly,variceal bleed. Liver functions & stucture- normal
TERMINOLOGY
Non cirrhotic portal fibrosis by ICMR in 1969 Idiopathic portal hypertension in Japan
NCPF
ETIOLOGY Infections bacterial inf. From gut. - umblical sepsis,diarrhoea in infancy & early childhood. chronic arsenicosis Auto- immune disorders Vinyl chloride Pro-thrombotic state (west)
infections/other agents chronic/ mild in Later age c/c antigenenemia/endotoxemia phlebosclerosis pre-sinusoidal fibrosis pre-sinusoidal resistance PORTAL HYPERTENSION
CLINICAL PROFILE
Age 2nd and 3rd decades M=F Hemetemesis & malaena (well-tolerated) Feeling of lump Esophagial varices Gastric varices Portal gastropathy Transient ascites
NATURAL HISTORY
Bleeding rate from varices high Mortality is low due to preserved liver functions. Transient ascites after bleed
HISTOPATHOLOGY Liver size & structure normal Obliterative portovenopathy -patchy & segmental subendothelial thickening of med & small portal vein - obliteration of small portal veins & emerg. new abberant portal channels
INVESTIGATIONS LFT- normal or near normal Pancytopenia due to hypersplenism Bone marrow hypercellular Coagulation profile and PLC- mild derranged Needle biopsy- absence of regenerative nodules - small portal vein obliteration - portal tract fibrosis - perivenular fibrosis - lack of hepatocellular injury
IMAGING
Usg- porto splenic axis dilated & patent - occ.thrombus in intrahepatic branch - echogenic boundary of PV (wall thickness)
ENDOSCOPY Esophagial varices 80-95% Varices are large at time of diagnosis Gastric varices Portal hypertensive gastropathy- rare Anorectal varices common
HEMODYNAMICS
DIAGNOSTIC FEATURES
Presence of mod- massive splenomegaly Evidence of portal hypertension,varices and /or collaterals Patent speno-portal axis & hepatic veins on ultrasound color doppler Normal or near normal liver functions Wedge hepatic venous pressure gradient- normal Liver histology- no cirrhosis & parenchymal injury
OTHER FEATURES
Absence of signs of CLD No decompensation except transient ascites Absence of serum markers of hep B &C No known etiology of liver disease USG DILATED & THICKENED portal vein with peripheral pruning & hyperechoic areas.
DIFFERENTIAL DIAGNOSIS
EHPVO 10 yr
NCPF 28 yr
Cirrhosis 40 yr
Ascites
+ to +++
++ ++
normal
normal
deranged
normal
normal
Shrunken,nodular
microscopic
normal
Usg
NCPF VS IPH
NCPF Age (years) M: F Hemetemesis/ malena 25-35 1:1 94 % IPH 43-56 1:3 40%
moderate common
Mildly raised Japan
COMPLICATIONS
Portal colopathy
Portal gastropathy
PORTAL BILIOPATHY
Term introduced in 1992. Abnormalities of extra & intra hepatic bile ducts with portal hypertension - identation by paracholedochal collaterals - localized strictures,angulation of duct - displc. Duct,focal narrowing,dilations left hepatic duct (mc) Symptoms- abd.pain,jaundice,fever complication- cholangitis,choledocholithiasis
PORTAL COLOPATHY
General management (icu ) - I v fluids, NGT, - blood transfusions Pharmocological therapy- octreotide,vasopressin - efficacy in NCPF is not known Endoscopic therapysclerotherapy & band ligation 80- 90% efficacy band ligation (preffered) Combination therapy- more effective in acute bleed - prevent rebleed
SCREENING
All patients with moderative- massive splenomegaly with NCPF should have a screening endoscopy
PRIMARY PROPHYLAXIS
Beta blockers Endoscopic therapy Combination of both- more effective Shunt sx if large esophageal varices with symptomatic splenomegaly, thrombocytopenia <20,000, repeated splenic infarcts Gastric varices- cyanoacrylate glue injection
Hypersplenism- splenectomy in symptomatic done with shunt sx. Portal biliopathy cholangitis & choledocholithiasis- biliary stenting,sphincterectomy, stone extraction.
PROGNOSIS Excellent Mortality from acute bleed is lower After successful eradication of esophagicgastro varices- 2- 5 yr survival is 100%
CONCLUSION Common cause of PHT in indian subcontinent Socially disadvantaged people Multifactorial etiogenesis Splenomegaly with complications of PTH & well preserved liver function Diagnosis- clinical,imaging,histology Proper management,life expectancy is normal Since 1990, there is decline in occurence